Trinity Biotech | TRIB - Cost Of Sales

Trinity Biotech reported $17.49M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbott ABT:US USD 4.59B 36M
Bayer BAYN:GR EUR 4.77B 521M
Bio Rad Laboratories BIO:US USD 332.96M 27.25M
Edap Tms EDAP:US EUR 7.95M 708K
Johnson & Johnson JNJ:US USD 7.76B 29M
Mesa Laboratories MLAB:US USD 21.52M 841K
Orasure Technologies OSUR:US USD 73.49M 3.22M
Roche Holding ROG:VX 8.95B 613M
Siemens SIE:GR EUR 11.1B 1.8B
Sientra SIEN:US USD 9.79M 1.02M
Surmodics SRDX:US USD 5.27M 330K
Thermo Fisher Scientific TMO:US USD 6.72B 340M
Tosoh 4042:JP JPY 218.35B 5.09B
Veracyte VCYT:US USD 26.83M 823K